Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Let's not enable TG2D to spread his poison through choosing his own subject header, researcher1.
People can see the latest RNS and his history to see the real picture here.
Brokers note was 70p before 2nd deal signing. 11 more pharmaceuticals giants will be negotiating with Andrew. See this heading back above £1 again very quickly.
TG2D, you are sounding a little desperate this morning?
"your" time.
TwoGood2Die, and yet you consider it worth spending so much of you time on a share that you consider a dog? Strange that ;-) I repeat: Your history and the latest RNS tells people all they need to know.
And you say you don't have a position on this! LOL! Pull the other one!!! Or maybe you work for someone that does?? Is that it?? LOL!
Alot of nonsense being spouted by certain day traders.
1. It takes a very, very long time to progress from a few test trials to mainstream commercial testing.
2. Parsortix is only FDA approved for testing 4% of cancers.
3. Cash is running out...
4. Eisai alot was said then when an RNS was relased months ago but silence now...no trading updates for way over six months...
This is the question.
Up 5.63%.
what I think will happen to the sp as soon as Angle get an order for the "Combined DNA Next Generation Sequencing of CTCs and ctDNA from the same blood sample" to monitor ANY cancer in ANY drug trial in the World that involves metastasised cancer. The potential here is nothing short of mind blowing as far as I can see. A way to monitor any cancer during a drug trial that has metastasised.......................................... Any metastasised cancer in Any cancer drug trial anywhere in the entire World. How many drug trials of this type are carried out in the World?
https://www.lse.co.uk/rns/AGL/breakthrough-clinical-results-b0km788ah9aflqm.html
All IMHO.
You'll have to forgive me, TwoGood2Die, but you lost my interest at "My view...". Your history and the latest RNS tells people all they need to know.
My view the 2023 financials will be diasterous and AGL are already nearly halfway through the current financial year and 85% down on the target of trebling revenues to £6m in order to reach cash breakeven next year...
I guess there is only around £6m or £7m cash remaining taking the business to December at best.
A cash placement seems highly likely at around 12p hence the RNS's with miniscule financials and all of which takes a long time to get any commercial traction given the very lengthy test regimes third parties need to adhere to and the lack of Parsortix FDA approval for testing a much wider range of cancers.
The much hyped RNS's are really prepping the ground for a heavily discounted placement on the very near future IMHO.
Bought some on Friday @ 16.10p so actually happy with that. I'm thinking a higher opening this morning at least. Obviously fuelled by media coverage, optimism and speculation surrounding a possible future bid from multiple interested parties. Will acquire some for my SIPP this morning, but at what price?. Don't actually care because they can just sit and wait quietly for true value to be achieved this year/next year. PS was here many moons ago and remember selling @ 108p. Didn't actually make a fortune as i remember buying @ 80p approx. Still, all good 👍👍. :o).
Hopefully in the mid twenties tomorrow. More RNs to drop. Looking very good
Gutted, but that's fine. As long as it stays low, I'll buy back for 50p target. Hopefully will be sun 20p Tuesday. Otherwise, first dip, I'll be back in.
The press coverage has been great for the company
Finally something to look forward to on Tuesday....
"This time next year we'll be millionaires"...
That's the Mail - who has the Times article to hand?? Feels like a leap into the 20s possible on Tuesday?
Nov 2022 to Jan 2023. No more shares have been issued.
I see no reason why the sp could not re-rate to around 50p a share in view of the recent fantastic news.
All IMHO.
I paid similar and thought it was still undervalued at £1.50 so held !
Lets see where it goes.....
Deepest sympathies Mercadooly. Tough, tough, tough... Let's pray for everyone's sakes this now moves fast.
So you will not find trial protocol etc
It’s a private study that involves Parsortix NHS in four cancer indications. 1000 subjects
Please explain?
Https://twitter.com/UroResearchNBT/status/1783071359800676823
thanks to 's****y' advfn
https://twitter.com/tymeric7/status/1786680910781272521
We have dragged our feet for some reason fo a long time. This was showing good results years ago. Out of support I paid £1 , never left. Now waiting for its true value.
Some people have died using the older test system. My son for one. Mist that he had an infection,